Vivos Therapeutics (VVOS) Asset Utilization Ratio (2021 - 2025)
Historic Asset Utilization Ratio for Vivos Therapeutics (VVOS) over the last 5 years, with Q3 2025 value amounting to 0.67.
- Vivos Therapeutics' Asset Utilization Ratio fell 2832.14% to 0.67 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.67, marking a year-over-year decrease of 2832.14%. This contributed to the annual value of 1.16 for FY2024, which is 236.44% up from last year.
- According to the latest figures from Q3 2025, Vivos Therapeutics' Asset Utilization Ratio is 0.67, which was down 2832.14% from 0.77 recorded in Q2 2025.
- Vivos Therapeutics' 5-year Asset Utilization Ratio high stood at 1.31 for Q4 2023, and its period low was 0.36 during Q3 2021.
- Moreover, its 5-year median value for Asset Utilization Ratio was 0.94 (2024), whereas its average is 0.84.
- As far as peak fluctuations go, Vivos Therapeutics' Asset Utilization Ratio surged by 12074.54% in 2022, and later tumbled by 2832.14% in 2025.
- Vivos Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.45 in 2021, then surged by 120.75% to 1.0 in 2022, then soared by 31.44% to 1.31 in 2023, then dropped by 25.16% to 0.98 in 2024, then tumbled by 31.71% to 0.67 in 2025.
- Its last three reported values are 0.67 in Q3 2025, 0.77 for Q2 2025, and 1.1 during Q1 2025.